Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A new wave of innovations within the DNA damage response
Qi Li, Wenyuan Qian, Yang Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 148
New Horizons of Synthetic Lethality in Cancer: Current Development and Future Perspectives
Viola Previtali, Greta Bagnolini, Andrea Ciamarone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 14, pp. 11488-11521
Open Access | Times Cited: 17
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways
Bowei Liu, Zhigang Peng, Hao Zhang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go
Vito Longo, Annamaria Catino, Michele Montrone, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3237-3237
Open Access | Times Cited: 10
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
Jiawen Zhang, Sihui Yu, Qiao Peng, et al.
Cancer Biology and Medicine (2024), pp. 1-20
Open Access | Times Cited: 8
DNA damage response in breast cancer and its significant role in guiding novel precise therapies
Jiayi Li, Ziqi Jia, Dong Lin, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy
Zhuang Zhu, Shaoming Li, Xiaopeng Yin, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130351-130351
Closed Access | Times Cited: 6
Screening and Testing for Homologous Recombination Repair Deficiency (HRD) in Breast Cancer: an Overview of the Current Global Landscape
Gordon R. Daly, Sindhuja Naidoo, Mohammad Alabdulrahman, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 8, pp. 890-903
Open Access | Times Cited: 4
Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts
Marina Kolesnichenko, Claus Scheidereit
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Targeting the DNA damage response in cancer
Guffanti Federica, Chiappa Michela, Giovanna Damia
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 4
DNA Damage Repair in Glioblastoma: A Novel Approach to Combat Drug Resistance
Ludovica Gaiaschi, Claudio Casali, Andrea Stabile, et al.
Cell Proliferation (2025)
Open Access
Poly(ADP-ribose) polymerase inhibitors in cancer therapy
Zi-Qi Zhu, Yujun Shi
Chinese Medical Journal (2025)
Open Access
Self-assembly GSH response based peptide-drug nanocombination synergistically promotes DNA damage for prostate cancer immunotherapy
Maosong Hu, Yuyu Zhu, Xinyi Tang, et al.
Chemical Engineering Journal (2025), pp. 160862-160862
Closed Access
Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers
Sarah C. Moser, Jos Jonkers
Cancer Discovery (2025) Vol. 15, Iss. 3, pp. 461-480
Closed Access
Mitochondrial priming and response to BH3 mimetics in “one-two punch” senogenic-senolytic strategies
Júlia López, Àngela Llop‐Hernández, Sara Verdura, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Multifunctional nanoparticle-mediated targeting of metabolic reprogramming and DNA damage response pathways to treat drug-resistant triple-negative breast cancer
Sifeng Zhu, Chao Sun, Zimin Cai, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113601-113601
Closed Access
Empowering PARP inhibition through rational combination: Mechanisms of PARP inhibitors and combinations with a focus on the treatment of metastatic castration-resistant prostate cancer
Jinge Zhao, Bo Tang, Pengfei Shen, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104698-104698
Closed Access
Signaling pathway dysregulation in breast cancer
Dinara Ryspayeva, Attila A. Seyhan, William MacDonald, et al.
Oncotarget (2025) Vol. 16, Iss. 1, pp. 168-201
Open Access
TAOK1 promotes filament formation in HR repair through phosphorylating USP7
Tian-Chen Zhu, Zhangping He, Shuting Li, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 12
Open Access
LDHB silencing enhances the effects of radiotherapy by impairing nucleotide metabolism and promoting persistent DNA damage
Haibin Deng, Fatlind Malsiu, Huixiang Ge, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
DNA damage response in cancer: New treatment strategies
Huiyuan Zhang
Deleted Journal (2025), pp. 1-13
Closed Access
Clinical-genomic characteristics of homologous recombination deficiency (HRD) in breast cancer: application model for practice
Juan Du, Lizhe Zhu, Chaorui Duan, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Occupational exposure to wildland firefighting and its effects on systemic DNA damage
Filipa Esteves, Joana Madureira, Carla Costa, et al.
International Journal of Hygiene and Environmental Health (2025) Vol. 266, pp. 114576-114576
Open Access
Current landscape and future directions of targeted-alpha-therapy for glioblastoma treatment
Loris Roncali, François Hindré, Edouard Samarut, et al.
Theranostics (2025) Vol. 15, Iss. 11, pp. 4861-4889
Open Access
Basis of Radiobiology and Its Relevance to Immunoradiotherapy
Hong Yu, Y Tang, Lin‐Lin Bu, et al.
(2025), pp. 19-34
Closed Access
Page 1 - Next Page

Scroll to top